GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
-11.87%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$4.03B
AUM Growth
+$4.03B
(-17%)
Cap. Flow
-$102M
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
32.81%
Holding
196
New
10
Increased
93
Reduced
75
Closed
18
Top Buys
| 1 |
CoStar Group
CSGP
|
$40.5M |
| 2 |
Chegg
CHGG
|
$35.5M |
| 3 |
Etsy
ETSY
|
$31.8M |
| 4 |
Enphase Energy
ENPH
|
$31.3M |
| 5 |
COUP
Coupa Software Incorporated
COUP
|
$26.5M |
Top Sells
| 1 |
Workiva
WK
|
$69.1M |
| 2 |
TWOU
2U, Inc.
TWOU
|
$40.8M |
| 3 |
Cricut
CRCT
|
$39.3M |
| 4 |
Globant
GLOB
|
$25.2M |
| 5 |
Flex
FLEX
|
$24M |
Sector Composition
| 1 | Technology | 36.83% |
| 2 | Healthcare | 19.87% |
| 3 | Industrials | 14.49% |
| 4 | Consumer Discretionary | 11.64% |
| 5 | Communication Services | 5.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSSE
101
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $8.34M | 0.21% |
1,043,916
+38,723
| +4% | +$309K |
|
102
Luxfer Holdings
LXFR
$354M
| $8.21M | 0.2% |
488,607
-440,183
| -47% | -$7.4M |
|
103
Portillo's
PTLO
$488M
| $8.09M | 0.2% |
329,336
+242,283
| +278% | +$5.95M |
|
104
Insmed
INSM
$30.3B
| $8.08M | 0.2% |
343,877
+38,214
| +13% | +$898K |
|
105
Xenon Pharmaceuticals
XENE
$2.99B
| $8.03M | 0.2% |
262,705
+45,404
| +21% | +$1.39M |
|
106
Fate Therapeutics
FATE
$115M
| $7.95M | 0.2% |
204,945
+71,544
| +54% | +$2.77M |
|
107
Apellis Pharmaceuticals
APLS
$3.51B
| $7.82M | 0.19% |
153,923
+70,322
| +84% | +$3.57M |
|
108
Hudson Technologies
HDSN
$447M
| $7.77M | 0.19% |
1,250,975
-577,985
| -32% | -$3.59M |
|
109
BioCryst Pharmaceuticals
BCRX
$1.74B
| $7.63M | 0.19% |
469,430
-661,148
| -58% | -$10.8M |
|
110
Ciena
CIEN
$13.4B
| $7.54M | 0.19% |
124,332
-1,645
| -1% | -$99.7K |
|
111
Acacia Research
ACTG
$312M
| $7.46M | 0.19% |
1,653,869
-699,825
| -30% | -$3.16M |
|
112
Onto Innovation
ONTO
$5.03B
| $7.46M | 0.19% |
85,846
+2,150
| +3% | +$187K |
|
113
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $7.38M | 0.18% |
742,158
+142,636
| +24% | +$1.42M |
|
114
WIX.com
WIX
$8.05B
| $7.35M | 0.18% |
70,347
+1,980
| +3% | +$207K |
|
115
The Beauty Health Co
SKIN
$254M
| $7.16M | 0.18% |
423,994
+250,770
| +145% | +$4.23M |
|
116
Arcus Biosciences
RCUS
$1.24B
| $7.13M | 0.18% |
226,050
+88,663
| +65% | +$2.8M |
|
117
American Well
AMWL
$112M
| $7.1M | 0.18% |
84,375
+13,602
| +19% | +$1.15M |
|
118
Nutanix
NTNX
$18.2B
| $7M | 0.17% |
261,055
+18,685
| +8% | +$501K |
|
119
Qualys
QLYS
$4.9B
| $6.78M | 0.17% |
47,633
+1,501
| +3% | +$214K |
|
120
Intellia Therapeutics
NTLA
$1.26B
| $6.73M | 0.17% |
92,609
-23,174
| -20% | -$1.68M |
|
121
AXT Inc
AXTI
$142M
| $6.65M | 0.17% |
947,901
+112,496
| +13% | +$790K |
|
122
AtriCure
ATRC
$1.73B
| $6.48M | 0.16% |
98,611
-15,676
| -14% | -$1.03M |
|
123
Rush Enterprises Class A
RUSHA
$4.44B
| $6.42M | 0.16% |
189,065
-206,775
| -52% | -$7.02M |
|
124
Beam Therapeutics
BEAM
$1.9B
| $6.2M | 0.15% |
108,227
+24,835
| +30% | +$1.42M |
|
125
Gentherm
THRM
$1.09B
| $6.01M | 0.15% |
82,256
-141,268
| -63% | -$10.3M |
|